Teva Pharmaceutical Industries net income 2006-2024

Published by
Matej Mikulic,
Feb 12, 2025

This statistic shows the net income of the pharmaceutical company Teva from 2006 to 2024. Teva Pharmaceutical Industries is one of the largest generic drug manufacturers in the world. However, for 2024, the company reported another net loss of over 1.6 billion U.S. dollars. Since 2017, this was Teva's seventh financial year with a negative financial result.

Net income of Teva Pharmaceutical Industries from 2006 to 2024 (in million U.S. dollars)

Loading statistic...

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2025

Region

Worldwide, Israel

Survey time period

2006 to 2024

Supplementary notes

Net income (loss) attributable to Teva.
2006-2021 figures were taken from previous annual reports.

Open this statistic in...
Spanish
Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Teva "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Teva

Global positioning

5

Key figures

5

Competitors

4

Costs and expenses

3

Regions and segments

3

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

TevaGlobal pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.